Michael Scolaro

Michael Scolaro

Nov 29, 2017

Group 6 Copy 256
-3
References
  • 1. https://www.ncbi.nlm.nih.gov/pubmed/26558876
  • 2. https://www.ncbi.nlm.nih.gov/pubmed/26558876
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can cockroaches help us cure tularemia?

Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also...

Crowdcuring the Blues: People, Technology and Research Against Depression

Depression is not a choice, but we can choose to do something about it. Depression is a single label used...

Targeted Drug Delivery by using Magnetic Nanoparticles

What if we could use a novel approach for delivering currently injectable drugs to the body without syringes...

Backer Badge Funded